Healthcare resource utilization comparing single-use ureteroscopes with real-time intrarenal pressure monitoring to other single-use ureteroscopes

Authors

  • Naeem Bhojani Division of Urology, Université de Montréal, Montréal, PQ, Canada
  • Connor M. Forbes Department of Urologic Sciences, The University of British Columbia, Vancouver, Canada
  • Ben H. Chew Department of Urologic Sciences, The University of British Columbia, Vancouver, Canada
  • Kathryn Morris Boston Scientific, Marlborough, MA, USA
  • Theodore Tsacogianis Boston Scientific, Marlborough, MA, USA
  • Jenifer White Boston Scientific, Marlborough, MA, USA
  • Sirikan Rojanasarot Boston Scientific, Marlborough, MA, USA
  • Abimbola Williams
  • Natalie Edwards Health Services Consulting Corporation, Boxborough, MA, USA
  • Manoj Monga Department of Urology, University of California San Diego School of Medicine, La Jolla, CA, USA

DOI:

https://doi.org/10.5489/cuaj.9608

Keywords:

ureteroscopy; lithotripsy; LithoVue Elite; single-use ureteroscope; intrarenal pressure; pressure monitoring capability; emergency department visit; inpatient admission

Abstract

Introduction: This study compared post-procedure healthcare resource utilization with LithoVue™ Elite (LVE) single-use digital flexible ureteroscope with pressure monitoring vs. other (non-pressure sensing) single-use ureteroscopes.

Methods: This retrospective, real-world study used the Premier PINC AI™ Healthcare Database. Adults aged 18+ undergoing ureteroscopy (URS) with lithotripsy between January 1,2024 and March 1, 2025, with ≥30-day post-URS followup were included. The primary outcomes were 10- and 30-day hospital resource utilization (HRU), a composite measure of emergency department (ED) visits or inpatient admission. Propensity score matching (1:3) balanced baseline characteristics. Multivariable logistic regression in the matched cohort adjusted for residual confounding.

Results: A total of 305 patients underwent LVE with pressure monitoring capability (mean [standard deviation (SD)] age 58.6 [16.1], 51.1% female) and 15 048 underwent other single-use ureteroscopes (mean [SD] age 58.7 [15.8], 51.7% female). After matching, 292 LVE patients were compared with 876 controls. Patients undergoing LVE with pressure monitoring capability experienced improved HRU outcomes at 10-day (4.5% vs. 8.7%; ARR 4.2 pp, p=0.016) and 30-day (7.2% vs. 12.0%; ARR 4.8 pp, p=0.019) vs. other single-use ureteroscopes. In adjusted analyses, LVE with pressure monitoring capability was associated with lower odds of HRU at 10-day (odds ratio [OR] 0.355, 95% confidence interval [CI] 0.175-0.718, p=0.004) and 30-day (OR 0.473, 95% CI 0.281-0.797, p=0.005). The odds of 10-day ED visits (OR 0.385, 95% CI 0.149-0.997, p=0.049) and 30-day inpatient admissions (OR 0.436, 95% CI 0.196-0.967, p=0.041) were significantly lower with LVE with pressure monitoring capability.

Conclusions: Use of LVE with pressure monitoring capability was associated with clinically meaningful reductions in early post-URS HRU vs. other single-use ureteroscopes.

Downloads

Download data is not yet available.

Downloads

Published

2026-03-30

How to Cite

Bhojani, N., Forbes, C. M., Chew, B. H., Morris, K., Tsacogianis, T., White, J., … Monga, M. (2026). Healthcare resource utilization comparing single-use ureteroscopes with real-time intrarenal pressure monitoring to other single-use ureteroscopes. Canadian Urological Association Journal, 20(8). https://doi.org/10.5489/cuaj.9608

Issue

Vol. 20 No. 8 (2026): CUAJ August

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.